Perceived impact of continuous glucose monitor use on quality of life and self-care for patients with type 2 diabetes
Evidence for clinical and quality of life benefits of Continuous Glucose Monitor (CGM) use in patients with type 1 diabetes (T1DM) is well established, but evidence in patients with type 2 diabetes (T2DM) is less robust or clear. This study aimed to help clarify the impact of CGMs for patients with...
Saved in:
Published in | Diabetes epidemiology and management Vol. 6; p. 100068 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Masson SAS
01.04.2022
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!